NewsRoom Articles - Page 121 of 202

ThursdayNov 18, 2021 9:49 am

Study Explores Link Between Obstructive Sleep Apnea and COVID-19

Obstructive sleep apnea ("OSA") is a common sleep-related breathing disorder that causes individuals to repeatedly start and stop breathing while they sleep. There exist different types of sleep apnea, with the most common one being obstructive sleep apnea. Common symptoms of this particular type of sleep apnea include loud snoring, excessive daytime sleepiness, episodes of stopped breathing and awakening abruptly, which may be accompanied by choking or gasping. A new study has found that patients with COVID-19 who suffer from obstructive sleep apnea have longer hospital stays and higher mortality rates when compared to patients with the coronavirus who don’t…

ThursdayNov 18, 2021 8:00 am

Nemaura Medical Inc. (NASDAQ: NMRD) Offers ‘First-of-a-Kind’ Device in Growing CGM Market

The global continuous glucose monitoring devices market size is expected to reach $19.04 billion in 2028 The increasing prevalence of diabetes, rising focus on preventive care are significant factors in the steady revenue growth Nemaura Medical’s sugarBEAT device allows individuals to make adjustments to diet and activity that can significantly change their lives According to a recent Reports and Data release, the global consumer monitoring (“CGM”) devices global market is forecast to see notable growth in the coming years (https://ibn.fm/LhWNO). Key companies operating in the space, including Nemaura Medical (NASDAQ: NMRD), are ideally positioned to benefit from that growth as they work…

WednesdayNov 17, 2021 1:22 pm

Mental Health Conditions, IBS Could Have Shared Origins

Irritable bowel syndrome (“IBS”) is a condition that affects one in every ten individuals globally. Its symptoms include bowel dysfunction and bloating and abdominal pain among others, which can significantly impact an individual’s life. Before a diagnosis can be made, clinicians usually consider the possibility of other ailments, including bowel cancer and Crohn’s disease. IBS is common in individuals who are prone to anxiety. While its causes aren’t well understood, a group of researchers recently discovered some genes that offer leads into its origin. The group was made up of more than 40 institutions, with the research being coordinated by…

TuesdayNov 16, 2021 9:30 am

Insufficient Sleep Compromising Students’ Mental Well-Being

A new study has found that more than one-half of students experience poor sleep quality, with researchers noting that lack so sleep has been associated to mental health issues. The study was published in the “Annals of Human Biology” journal. It is part of the longitudinal study on the lifestyle and health of students in universities. The study involved 1,113 women and men who attend university on a full-time basis, all aged between 16 and 25. Each participant was asked about their socioeconomic status and sleep quality, with researchers also assessing their body mass index. The researchers used this data…

MondayNov 15, 2021 9:30 am

Veterans Urged to Undergo Lung Cancer Screening During Lung Cancer Awareness Month

Cancer begins when old cells in an individual’s body begin to mutate instead of dying, growing out of control and creating abnormal cells. A team of oncologists, cardiothoracic surgeons and specialized nurse navigators from the Central Virginia Care System are urging veterans as well as individuals in high-risk groups to get screened for lung cancer this November, which is designated as Lung Cancer Awareness Month. Lung cancer is a type of cancer that starts in the lungs and is among the leading causes of cancer deaths around the globe. The primary types of lung cancer are non-small cell lung cancer…

MondayNov 15, 2021 8:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Files Technology Patent Application Covering Bioavailability-Enhancing, Nanoemulsion-Empowered Formulations

Mydecine has filed a technology patent application that allows for the creation of nanoemulsion-empowered formulations to improve, stabilize, and increase the bioavailability of ingredients The company aims to use the nanoemulsion technology to enhance the bioavailability and optimize the delivery of compounds that are inspired by traditional ingredients In September, Mydecine filed its final patent application for MYCO-003, one of its lead drug candidates for enhanced treatment of anxiety and post-traumatic stress disorder MYCOF is steadily strengthening its IP portfolio as it seeks to reimagine the treatment of mental health and addiction Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF), an…

FridayNov 12, 2021 12:19 pm

Recent Sector News Reveals Positive Data in Psychedelic Treatments For Depression as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Nears Launch of Synthetic Psilocybin Trials

Pharmaceutical company Tryp Therapeutics is developing a proprietary synthetic hallucinogen as potential medical solutions for select unmet health needs, with a focus on taking psychedelic therapeutics beyond mental health The company recently attended the Wonderland: Miami where Compass Pathways unveiled highly anticipated data from their Phase 2b trial in treatment-resistant depression Tryp’s Chairman and CEO Greg McKee served on a panel at Wonderland: Miami discussing the potential of synthetic psilocybin in chronic pain indications and the importance of supporting industry wins Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) Chairman and CEO Greg McKee recently participated in Microdose’s Wonderland: Miami conference as…

FridayNov 12, 2021 9:30 am

Study Finds Neuroinflammation Protein Decreases Rate of Survival in Male Patients with Glioblastoma

Glioblastoma is a common and aggressive type of cancer that occurs in the spinal cord or brain. This cancer is almost twice as likely to affect males and is mostly found in adults. About 12,000 individuals are diagnosed with this cancer in the United States annually. Patients diagnosed with this cancer usually experience many symptoms, including changes in personality, memory loss, persistent headaches and seizures. Now new research has found an association between glioblastoma patient survival outcomes and translocator protein 18 kDa, which is a neuro-inflammation biomarker. This discovery could help the medical and scientific community better understand why glioblastoma…

ThursdayNov 11, 2021 12:35 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Launches Transformative Training Program for Psychedelic Facilitators

The EMBARK program represents the broad spectrum of ways in which therapeutic benefits might be experienced Program offers psychedelic clinical trial facilitators foundational training to provide skillful, ethical care to participants receiving psychedelic treatment EMBARK is built around open architecture to support varieties of psychedelic experience within a coherent therapeutic framework In a climate where psychedelic treatments are increasing in usage and acceptance, the importance of providing support and guidance in the space becomes even more important. With that in mind, Cybin (NEO: CYBN) (NYSE American: CYBN) has launched its proprietary EMBARK Psychedelic Facilitator Training Program (https://ibn.fm/3lzkp). Named for the program’s…

ThursdayNov 11, 2021 10:41 am

How Virtual Monitoring Can Transform Patients’ Care

The advancement of innovations and technology in different sectors has made it easier to access information on almost anything you can think of. The healthcare sector in particular has experienced various changes, with medical technology reshaping healthcare, leading to the evolution of patient care and management. These advances in healthcare technology have made it possible for patients to connect with their physicians at any time, which has redefined the patient-physician connection. The role of remote monitoring in healthcare has also been highlighted with the advancement of medical technology, especially in the early detection and treatment of cardiovascular ailments. Today, we…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Study Explores Link Between Obstructive Sleep Apnea and COVID-19

Nemaura Medical Inc. (NASDAQ: NMRD) Offers ‘First-of-a-Kind’ Device in Growing CGM Market

Mental Health Conditions, IBS Could Have Shared Origins

Insufficient Sleep Compromising Students’ Mental Well-Being

Veterans Urged to Undergo Lung Cancer Screening During Lung Cancer Awareness Month

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Files Technology Patent Application Covering Bioavailability-Enhancing, Nanoemulsion-Empowered Formulations

Recent Sector News Reveals Positive Data in Psychedelic Treatments For Depression as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Nears Launch of Synthetic Psilocybin Trials

Study Finds Neuroinflammation Protein Decreases Rate of Survival in Male Patients with Glioblastoma

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Launches Transformative Training Program for Psychedelic Facilitators

How Virtual Monitoring Can Transform Patients’ Care

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search